
Dayton, Ohio--(Newsfile Corp. - September 14, 2026) - Alyea Therapeutics, a wholly owned subsidiary of AIFC Corporation (NASDAQ: AIFC), is pleased to announce its participation in the upcoming 3rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Centre Toronto Hotel. Amol Soin, MD, Chief Executive Officer of Alyea Therapeutics, will participate as a Featured Company and will hold one-on-one meetings with interested investors and capital markets professionals.








